Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KELLY SERVICES INCKELYA · Entity 5372 | Director | May 09, 2024 | May 11, 2024 |
| MASCO CORP /DE/MAS · Entity 3389 | Director | August 01, 2024 | August 05, 2024 |
| ROCKWELL AUTOMATION, INCROK · Entity 906 | Director | February 10, 2026 | February 11, 2026 |
| Sierra Oncology, Inc.SRRA · Entity 125698 | Director | June 11, 2019 | June 12, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KELLY SERVICES INC
Report date May 09, 2024 · Filed May 11, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, Par Value $1SEC Table I · non-derivative | Direct | 100,296 |
Reported balance
After 2024-05-09 transaction · row 1
1 source rowRow 1 · 2024-05-09 · Grant · Acquired 6,811 · Balance 100,296 F1: Stock granted under the terms of the Equity Incentive Plan. The award represents a portion of the annual retainer paid to covered members of Kelly Services, Inc. Board of Directors. The stock was valued at close of market on 5/9/2024 at $22.02 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock granted under the terms of the Equity Incentive Plan. The award represents a portion of the annual retainer paid to covered members of Kelly Services, Inc. Board of Directors. The stock was valued at close of market on 5/9/2024 at $22.02 per share.
MASCO CORP /DE/
Report date August 01, 2024 · Filed August 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy 2006 Trust | 32,370 |
Reported balance
After 2024-08-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-08-01 · Gift · Disposed 1,868 · Balance 32,370 |
| Common StockSEC Table I · non-derivative | Direct | 5,494 |
Reported balance
Holding disclosure · report date 2024-08-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,494 |
| Common StockSEC Table I · non-derivative | IndirectBy Appointive Trust | 80 |
Reported balance
Holding disclosure · report date 2024-08-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 80 |
ROCKWELL AUTOMATION, INC
Report date February 10, 2026 · Filed February 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,497 |
Ending reported balance
After 2026-02-10 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-02-10 · Exercise / conversion · Acquired 1,508 · Balance 13,843 Row 2 · 2026-02-10 · Exercise / conversion · Acquired 154 · Balance 13,997 Row 3 · 2026-02-10 · Exercise / conversion · Acquired 500 · Balance 14,497 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-10 · Exercise / conversion · Disposed 1,508 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Rockwell Automation common stock. F2: These restricted stock units, which were delivered as director compensation under the 2003 Directors Stock Plan, were payable upon retirement. Mr. Parfet retired from the Company's Board on February 10, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-10 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-02-10 · Exercise / conversion · Disposed 154 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Rockwell Automation common stock. F2: These restricted stock units, which were delivered as director compensation under the 2003 Directors Stock Plan, were payable upon retirement. Mr. Parfet retired from the Company's Board on February 10, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-10 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-02-10 · Exercise / conversion · Disposed 500 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Rockwell Automation common stock. F2: These restricted stock units, which were delivered as director compensation under the 2003 Directors Stock Plan, were payable upon retirement. Mr. Parfet retired from the Company's Board on February 10, 2026. |
| Common StockSEC Table I · non-derivative | IndirectBy Parfet Family Trust | 17 |
Reported balance
Holding disclosure · report date 2026-02-10 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 17 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Rockwell Automation common stock.
F2: These restricted stock units, which were delivered as director compensation under the 2003 Directors Stock Plan, were payable upon retirement. Mr. Parfet retired from the Company's Board on February 10, 2026.
Sierra Oncology, Inc.
Report date June 11, 2019 · Filed June 12, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.66 · Expires 2029-06-11 | Direct | 30,000 |
Reported balance
After 2019-06-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-11 · Grant · Acquired 30,000 · Balance 30,000 F1: The option vests as to 8.333% of the total shares monthly, beginning on July 11, 2019, with 100% of the total shares vested and exercisable on June 11, 2020, subject to the reporting person's provision of service to the issuer on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to 8.333% of the total shares monthly, beginning on July 11, 2019, with 100% of the total shares vested and exercisable on June 11, 2020, subject to the reporting person's provision of service to the issuer on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2018 Filed May 15, 2018 14:00 UTC | MASCO CORP /DE/ MAS · Entity 3389 | GrantCommon Stock | 3,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-009287 · doc4.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,699 F1 · price: N/A Read SEC document |
| May 09, 2018 Filed May 10, 2018 18:36 UTC | KELLY SERVICES INC KELYA · Entity 5372 | GrantClass A Common Stock, Par Value $1 | 3,577 | $30.75 | $109,992.75 |
DisclosureSEC source: 0001127602-18-016918 · form4.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,097 F1 · shares: Stock granted under the terms of the Equity Incentive Plan. The award represents a portion of the annual retainer paid to covered members of Kelly Services, Inc. Board of Directors. The stock was valued at close of market on 5/9/2018 at $30.75 per share. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 01:14 UTC | ROCKWELL AUTOMATION, INC ROK · Entity 906 | GrantCommon Stock | 213 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-18-000516 · form.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,573 F1 · shares: Shares delivered as compensation for service as a director under the 2003 Directors Stock Plan. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 16:20 UTC | Sierra Oncology, Inc. SRRA · Entity 125698 | OtherCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002720 · doc4.xml · nonDerivative · entry 5 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,235 F6 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by AVLLC to its members. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 16:20 UTC | Sierra Oncology, Inc. SRRA · Entity 125698 | OtherCommon Stock | 2,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002720 · doc4.xml · nonDerivative · entry 4 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Apjohn Ventures, LLC Disclosed balance after: 0 F5 · kind: Represents a pro rata distribution of shares of the issuer's common stock held by AVLLC to its members. F3 · ownership.nature: The reporting person is a managing member of Apjohn Ventures, LLC ("AVLLC"), and has shared voting and shared dispositive power over the shares held by AVLLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 16:20 UTC | Sierra Oncology, Inc. SRRA · Entity 125698 | OtherCommon Stock | 1,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002720 · doc4.xml · nonDerivative · entry 3 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Apjohn Ventures, LLC Disclosed balance after: 2,760 F4 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by Apjohn Ventures Annex Fund LP to its limited partners. F3 · ownership.nature: The reporting person is a managing member of Apjohn Ventures, LLC ("AVLLC"), and has shared voting and shared dispositive power over the shares held by AVLLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 16:20 UTC | Sierra Oncology, Inc. SRRA · Entity 125698 | OtherCommon Stock | 1,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002720 · doc4.xml · nonDerivative · entry 2 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Apjohn Ventures, LLC Disclosed balance after: 1,692 F1 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by Apjohn Ventures Fund, LP to its limited partners. F3 · ownership.nature: The reporting person is a managing member of Apjohn Ventures, LLC ("AVLLC"), and has shared voting and shared dispositive power over the shares held by AVLLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 16:20 UTC | Sierra Oncology, Inc. SRRA · Entity 125698 | OtherCommon Stock | 3,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002720 · doc4.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Donald R. Parfet 2006 Trust, Dated May 1, 2006 Disclosed balance after: 390,913 F1 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by Apjohn Ventures Fund, LP to its limited partners. F2 · ownership.nature: The reporting person is the trustee of the Donald R. Parfet 2006 Trust, Dated May 1, 2006. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 15:07 UTC | ROCKWELL AUTOMATION, INC ROK · Entity 906 | GrantCommon Stock | 512 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002840 · form.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,360 F1 · shares: Shares delivered as compensation for service as a director under the 2003 Directors Stock Plan. Read SEC document |
| June 13, 2017 Filed Jun 14, 2017 17:31 UTC | Sierra Oncology, Inc. SRRA · Entity 125698 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001209191-17-039877 · doc4.xml · derivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-06-13 F1 · derivative.exercise_date: The option vests as to 8.333% of the total shares monthly, beginning on July 13, 2017, with 100% of the total shares vested and exercisable on June 13, 2018, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| June 09, 2017 Filed Jun 12, 2017 17:42 UTC | KELLY SERVICES INC KELYA · Entity 5372 | SaleClass A Common Stock, Par Value $1 | 22,029 | $23.10 | $508,850.07 |
DisclosureSEC source: 0001127602-17-021146 · form4.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,520 F1 · price: 22,029 shares were sold at an average price of $23.0991 per share. Two-hundred-thirty-two individual trades were executed at prices ranging from $22.91 per share to $23.42 per share. Read SEC document |
| May 12, 2017 Filed May 16, 2017 14:06 UTC | MASCO CORP /DE/ MAS · Entity 3389 | GrantCommon Stock | 3,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-009839 · doc4.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,019 F1 · price: N/A Read SEC document |
| May 11, 2017 Filed May 15, 2017 17:34 UTC | KELLY SERVICES INC KELYA · Entity 5372 | GrantClass A Common Stock, Par Value $1 | 3,493 | $22.90 | $79,989.70 |
DisclosureSEC source: 0001127602-17-018031 · form4.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,549 F1 · shares: Stock granted under the terms of the Equity Incentive Plan. The award represents a portion of the annual retainer paid to covered members of Kelly Services, Inc. Board of Directors. The stock was valued at the close of market on 5/11/2017 at $22.90 per share. Read SEC document |
| February 07, 2017 Filed Feb 8, 2017 22:22 UTC | ROCKWELL AUTOMATION, INC ROK · Entity 906 | GrantCommon Stock | 268 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-000486 · form.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,848 F1 · shares: Shares delivered as compensation for service as a director under the 2003 Directors Stock Plan. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 18:12 UTC | Sierra Oncology, Inc. DNAI · Entity 125698 | OtherCommon Stock | 2,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-149450 · doc4.xml · nonDerivative · entry 5 Parfet Donald R · CIK 0001305641 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,855 F6 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by AVLLC to its members. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 18:12 UTC | Sierra Oncology, Inc. DNAI · Entity 125698 | OtherCommon Stock | 4,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-149450 · doc4.xml · nonDerivative · entry 4 Parfet Donald R · CIK 0001305641 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Apjohn Ventures, LLC Disclosed balance after: 0 F5 · kind: Represents a pro rata distribution of shares of the issuer's common stock by AVLLC to its members. F3 · ownership.nature: The reporting person is a managing member of Apjohn Ventures, LLC ("AVLLC"), and has shared voting and shared dispositive power over the shares held by AVLLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 18:12 UTC | Sierra Oncology, Inc. DNAI · Entity 125698 | OtherCommon Stock | 1,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-149450 · doc4.xml · nonDerivative · entry 3 Parfet Donald R · CIK 0001305641 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Apjohn Ventures, LLC Disclosed balance after: 4,806 F4 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by Apjohn Ventures Annex Fund LP to it limited partners. F3 · ownership.nature: The reporting person is a managing member of Apjohn Ventures, LLC ("AVLLC"), and has shared voting and shared dispositive power over the shares held by AVLLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 18:12 UTC | Sierra Oncology, Inc. DNAI · Entity 125698 | OtherCommon Stock | 3,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-149450 · doc4.xml · nonDerivative · entry 2 Parfet Donald R · CIK 0001305641 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Apjohn Ventures, LLC Disclosed balance after: 3,383 F1 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by Apjohn Ventures Fund, LP to its limited partners. F3 · ownership.nature: The reporting person is a managing member of Apjohn Ventures, LLC ("AVLLC"), and has shared voting and shared dispositive power over the shares held by AVLLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 18:12 UTC | Sierra Oncology, Inc. DNAI · Entity 125698 | OtherCommon Stock | 6,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-149450 · doc4.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By Donald R. Parfet 2006 Trust, Dated May 1, 2006 Disclosed balance after: 387,530 F1 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by Apjohn Ventures Fund, LP to its limited partners. F2 · ownership.nature: The reporting person is the trustee of the Donald R. Parfet 2006 Trust, Dated May 1, 2006. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 16:49 UTC | ROCKWELL AUTOMATION, INC ROK · Entity 906 | GrantCommon Stock | 726 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-16-006890 · form.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,580 F1 · shares: Shares delivered as compensation for service as a director under the 2003 Directors Stock Plan. Read SEC document |
| September 29, 2016 Filed Sep 30, 2016 18:19 UTC | Sierra Oncology, Inc. DNAI · Entity 125698 | OtherCommon Stock | 1,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-143405 · doc4.xml · nonDerivative · entry 5 Parfet Donald R · CIK 0001305641 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,452 F6 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by AVLLC to its members. Read SEC document |
| September 29, 2016 Filed Sep 30, 2016 18:19 UTC | Sierra Oncology, Inc. DNAI · Entity 125698 | OtherCommon Stock | 2,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-143405 · doc4.xml · nonDerivative · entry 4 Parfet Donald R · CIK 0001305641 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By Apjohn Ventures, LLC Disclosed balance after: 0 F5 · kind: Represents a pro rata distribution of shares of the issuer's common stock held by AVLLC to its members. F3 · ownership.nature: The reporting person is a managing member of Apjohn Ventures, LLC ("AVLLC"), and has shared voting and shared dispositive power over the shares held by AVLLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 29, 2016 Filed Sep 30, 2016 18:19 UTC | Sierra Oncology, Inc. DNAI · Entity 125698 | OtherCommon Stock | 711 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-143405 · doc4.xml · nonDerivative · entry 3 Parfet Donald R · CIK 0001305641 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By Apjohn Ventures, LLC Disclosed balance after: 2,403 F4 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by Apjohn Ventures Annex Fund LP to its limited partners. F3 · ownership.nature: The reporting person is a managing member of Apjohn Ventures, LLC ("AVLLC"), and has shared voting and shared dispositive power over the shares held by AVLLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 29, 2016 Filed Sep 30, 2016 18:19 UTC | Sierra Oncology, Inc. DNAI · Entity 125698 | OtherCommon Stock | 1,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-143405 · doc4.xml · nonDerivative · entry 2 Parfet Donald R · CIK 0001305641 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By Apjohn Ventures, LLC Disclosed balance after: 1,692 F1 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by Apjohn Ventures Fund, LP to its limited partners. F3 · ownership.nature: The reporting person is a managing member of Apjohn Ventures, LLC ("AVLLC"), and has shared voting and shared dispositive power over the shares held by AVLLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 29, 2016 Filed Sep 30, 2016 18:19 UTC | Sierra Oncology, Inc. DNAI · Entity 125698 | OtherCommon Stock | 3,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-143405 · doc4.xml · nonDerivative · entry 1 Parfet Donald R · CIK 0001305641 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By Donald R. Parfet 2006 Trust, Dated May 1, 2006 Disclosed balance after: 380,763 F1 · kind: Represents shares of the issuer's common stock received in connection with a pro rata distribution of shares held by Apjohn Ventures Fund, LP to its limited partners. F2 · ownership.nature: The reporting person is the trustee of the Donald R. Parfet 2006 Trust, Dated May 1, 2006. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.